DNMT1 and neoplasm: CSCs often participate in the epithelial–mesenchymal transition via the induction of an embryonic genetic program that re-expresses the genes SOX2, OCT4, NANOG, and DNMT1, and display stem cell-like profiles that contribute to tumor initiation, progression towards invasive phenotypes, therapeutic failure, and/or tumor recurrence [88].